Faculty of Health Sciences, Universidade da Beira Interior, Covilhã, Portugal; CHUC Lupus Clinic, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Portugal.
Rheumatology and Clinical Immunology Unit and Clinical and Experimental Science Department ASST Spedali Civili and University of Brescia, Brescia, Italy.
Autoimmun Rev. 2024 Jan;23(1):103428. doi: 10.1016/j.autrev.2023.103428. Epub 2023 Aug 25.
Systemic lupus erythematosus (SLE) is a heterogeneous condition making assessment of disease activity challenging. However, thorough assessment is essential to evaluate patients longitudinally, to guide therapeutic decisions, and for clinical trials. Currently, the most popular disease activity index in clinical practice and trials is SLEDAI-2K. Its main advantage is ease of use, but significant weaknesses of SLEDAI-2K are omission of several serious manifestations, inability to capture change within an organ system, and fixed severity weightings that are often inappropriate. Recently several groups have developing improved tools. We report here the debate held at CORA meeting on this issue. SLE-DAS includes 17 weighted clinical and laboratory parameters including continuous measures in 4 items with an online calculator. A higher sensitivity to change compared to SLEDAI-2K has been demonstrated in its validation studies. Easy BILAG is an improved format of the BILAG-2004 that retains its content but greatly simplified. Its scoring using a single-page form that incorporates concise definitions for key terms next to clinical items. Easy-BILAG demonstrates higher accuracy and less variability and increased and better user feedback compared to the standard BILAG-2004 format. Both the indices discussed at CORA showed an advantage in measuring disease activity compared to SLEDAI.
系统性红斑狼疮(SLE)是一种异质性疾病,评估疾病活动度具有挑战性。然而,彻底的评估对于纵向评估患者、指导治疗决策以及临床试验都是至关重要的。目前,临床实践和临床试验中最流行的疾病活动指数是 SLEDAI-2K。它的主要优点是易于使用,但 SLEDAI-2K 也存在明显的弱点,例如遗漏了几种严重表现、无法捕捉一个器官系统内的变化,以及固定的严重程度权重往往不恰当。最近,有几个研究小组已经开发出了改进的工具。我们在此报告了在 CORA 会议上就此问题进行的辩论。SLE-DAS 包括 17 个加权的临床和实验室参数,其中 4 项包含连续测量,并且有在线计算器。其验证研究表明,与 SLEDAI-2K 相比,它具有更高的变化敏感性。EasyBILAG 是 BILAG-2004 的改进版本,保留了其内容,但大大简化了。它的评分使用单页表格,在临床项目旁边包含关键术语的简明定义。与标准的 BILAG-2004 格式相比,Easy-BILAG 具有更高的准确性、更小的变异性、更高的用户反馈和更好的用户反馈。在 CORA 讨论的这两个指数都显示出在测量疾病活动度方面优于 SLEDAI。